Rebecca Kylie Halligan

6PUBLICATIONS
27CO-AUTHORS
Medical infection agents (incl. prions)AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 30, 2026
COXFA4L2 upregulation preserves residual cytochrome c oxidase activity in COXFA4-related Leigh-like encephalopathy.

|Sep 29, 2023
Histologically atypical case of Gaucher disease type 1.

Jessica Sabljak, Oliver Heath, Rebecca Halligan

|Sep 13, 2023
Interstitial lung disease and pancreatic exocrine insufficiency in CADDS: Phenotypic expansion and literature review.

Oliver Heath, Dinusha Pandithan, James Pitt

|May 13, 2022
Understanding the role of SGLT2 inhibitors in glycogen storage disease type Ib: the experience of one UK centre.

Rebecca K Halligan, R Neil Dalton, Charles Turner

|May 12, 2021
The natural history of glycogen storage disease type Ib in England: A multisite survey.

Rebecca Halligan, Fiona J White, Bernd Schwahn

|Jan 09, 2021
Wormian bones: thinking beyond osteogenesis imperfecta.

Rebecca Kylie Halligan, Leanne Royle, Claire Lloyd

Pageof 1

Frequent Collaborators

2 joint publications

Oliver Heath

1 joint publications

Dinusha Pandithan

1 joint publications

James Pitt

1 joint publications

Elena Savva